has subject area Animals Biological Availability Canagliflozin Chemistry, Pharmaceutical Diabetes Mellitus, Type 2 Drug Carriers Drug Liberation Humans Hypoglycemic Agents Lipids Male Nanostructures Particle Size Rats Sodium-Glucose Transporter 2 Inhibitors Solubility
Keywords Box-Behnken design Canagliflozin hemihydrate bioavailability. ex-vivo permeability in-vitro release nanostructured lipid carriers